Clinical Trial Update: Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine plus either carboplatin or cisplatin in patients with stage IIIB/IV or recurrent non-small cell lung cancer has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Platinol (cisplatin)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED